Concepedia
Statistics
Publications
9
Citations
369
H-Index
Active since
2006
Affiliations
Duke University(Current)
Cleveland Clinic
Vanderbilt University Medical Center
University of California, San Francisco
Stanford University
Ahmed Galal is an author at Duke University specializing in immunotherapy, immunology, and medicine.
Publications per year
2006–2024
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
Anas Younes, Yasuhiro Oki, R. Gregory Bociek et al. · The Lancet Oncology · 2011 · 195 citations · Full text
Medicine, Oncology, Pharmacotherapy +11
Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders
Mohamed‐Rachid Boulassel, A-L Herr, M Edwardes et al. · Hematology · 2006 · 39 citations
Medicine, Hematology, Immunology +17
Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis
Amneet Bajwa, Qiuhong Zhao, Marcus Geer et al. · Blood Advances · 2024 · 39 citations · Full text
Life Sciences, Immunology, Clinical Immunology +11
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W. Roloff, Ibrahim Aldoss, Noam E. Kopmar et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text
Life Sciences, Hematology, Immunology +13
Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
Brian T. Hill, Caroline J Roth, Rachel Kositsky et al. · Blood · 2021 · 14 citations
Medicine, Hematology, Oncology +13
1–5 of 9